Showing results (531-540 of 582) with videos related to

Sort By:
Pageof 59
Cancer Research|January 1, 1994
Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivityR J McRipley, P E Burns-Horwitz, P M Czerniak, et al.
Cancer Research|October 25, 2013
TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapyChan Gao, Anna Kozlowska, Sergey Nechaev, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infectionGhislaine Gallez-Hawkins, Lia Thao, Simon F Lacey, et al.
Frontiers in Oncology|March 6, 2023
Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine modelThuy Phan, Vu H Nguyen, Rui Su, et al.
Communications Medicine|February 17, 2024
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virusFlavia Chiuppesi, John A Zaia, Miguel-Angel Gutierrez-Franco, et al.
The Journal of Pathology|July 13, 2002
Expert system support using a Bayesian belief network for the classification of endometrial hyperplasiaM L Morrison, W G McCluggage, G J Price, et al.
International Journal of Biological Sciences|July 9, 2021
Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancerThuy Phan, Vu H Nguyen, Ralf Buettner, et al.
Haematologica|June 22, 2001
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patientsP Gameiro, S Vieira, P Carrara, et al.
Blood|April 20, 2004
Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cellsZhongde Wang, Corinna La Rosa, Shahram Mekhoubad, et al.
Frontiers in Immunology|November 27, 2025
Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variantsAmany Elsharkawy, Shannon Stone, Anchala Guglani, et al.
Pageof 59